Sphera Funds Management’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Sphera Funds Management’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-77,000	Closed	-$8.05M	–	106
2019 Q4	$8.05M	Buy	77,000 +3,000	+4%	+$336K	0.66%	28
2019 Q3	$8.51M	Buy	+74,000	New	+$11.2M	1.32%	15
2019 Q1	–	Sell	-77,000	Closed	-$7.5M	–	131
2018 Q4	$7.5M	Buy	+77,000	New	+$10.1M	0.85%	28
2016 Q4	–	Sell	-31,000	Closed	-$4.12M	–	127
2016 Q3	$4.12M	Sell	31,000 -9,000	-23%	-$860K	0.67%	35
2016 Q2	$3.66M	Buy	+40,000	New	+$3.37M	0.95%	31
2016 Q1	–	Sell	-23,790	Closed	-$1.65M	–	131
2015 Q4	$1.65M	Sell	23,790 -19,310	-45%	-$1.57M	0.24%	94
2015 Q3	$3.94M	Sell	43,100 -400	-0.9%	-$44.5K	0.5%	41
2015 Q2	$5.34M	Buy	43,500 +8,500	+24%	+$964K	0.52%	37
2015 Q1	$3.19M	Buy	+35,000	New	+$2.84M	0.33%	74

Other funds holding GWPH

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

MGIM

M&G Investment Management London, United Kingdom $28.2B AUM 25.87% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Sphera Funds Management's GWPH Position: Q1 2020 in Review

Sphera Funds Management sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q1 2020, closing a stake of 77,000 shares — an estimated $8.05M sold.

Sphera Funds Management first reported a position in GWPH in Q1 2015 and held it in 9 quarters. The position peaked at $8.51M in Q3 2019. 289 funds tracked by Wall St. Rank hold GWPH as of Q1 2020.

Sphera Funds Management reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q1 2020 after selling out during the quarter.
Sphera Funds Management sold 77,000 GW Pharmaceuticals Plc American Depositary Shares shares in Q1 2020, an estimated $8.05M.
Sphera Funds Management first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q1 2015 and held it in 9 quarters.
Sphera Funds Management's GW Pharmaceuticals Plc American Depositary Shares position peaked at $8.51M in Q3 2019.
289 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q1 2020.

Based on Sphera Funds Management's 13F filing for Q1 2020, filed 14 May 2020.